Literature DB >> 28449252

Serum phosphorus levels and fracture following renal transplantation.

Jasna Aleksova1,2,3, Phillip Wong1,2,3, William R Mulley3,4, Kay Weng Choy5, Robert McLachlan1,2,3, Peter R Ebeling1,3, Peter G Kerr3,4, Frances Milat1,2,3.   

Abstract

PURPOSE: Increased fracture rates are observed in renal transplant recipients (RTRs) compared with the general population. Risk factors include age, diabetes, dialysis vintage, immunosuppression and mineral and bone disorders.1 Low serum phosphorus levels occur post-transplantation; however, its relationship with fracture risk has not been evaluated. The purpose of this study was to evaluate risk factors for fracture in RTRs at a single tertiary referral centre.
METHODS: A retrospective cross-sectional analysis of 146 patients (75 M, 71 F) who had been referred for dual energy X-ray densitometry (DXA) post-renal transplantation was performed. Aetiology of end stage kidney disease (ESKD), duration of dialysis, parathyroidectomy history, immunosuppression regimen, bone mineral density (BMD), biochemistry and fractures were documented. Statistical analyses included univariable and multivariable regression.
RESULTS: The mean age of patients was 54 years and mean time post-transplantation 6.7 years. A total of 79 fractures occurred in 52 patients (35%), with 40 fractures occurring post-transplantation. Ankle/foot fractures were most common (48%). Lower serum phosphorus levels and declining femoral neck (FN) T-score and were associated with fractures in both univariable and multivariable regression analyses after adjusting for age, gender, weight, estimated glomerular filtration rate and pre-transplant history of fracture (P=.011 and P=.042 respectively). The relationship between serum phosphorus and fracture remained significant independent of FN T-score, parathyroid hormone levels, parathyroidectomy status and prednisolone use.
CONCLUSION: Fracture was common post-renal transplantation. Lower serum phosphorus levels and declining FN T-scores were associated with fractures. The mechanism of this previously unreported observation requires further evaluation in prospective studies.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  fractures; phosphorus; renal transplant

Mesh:

Substances:

Year:  2017        PMID: 28449252     DOI: 10.1111/cen.13363

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Predictors of bone fractures in a single-centre cohort of hemodialysis patients: a 2-year follow-up study.

Authors:  Ludmila Brunerová; Renata Lažanská; Petr Kasalický; Jana Verešová; Jana Potočková; Alena Fialová; Ivan Rychlík
Journal:  Int Urol Nephrol       Date:  2018-08-16       Impact factor: 2.370

2.  Therapy for persistent hypercalcemic hyperparathyroidism post-renal transplant: cinacalcet versus parathyroidectomy.

Authors:  Gabriel Giollo Rivelli; Marcelo Lopes de Lima; Marilda Mazzali
Journal:  J Bras Nefrol       Date:  2020 Jul-Sep

3.  Prevalence of Vertebral Fractures and Their Prognostic Significance in the Survival in Patients with Chronic Kidney Disease Stages 3‒5 Not on Dialysis.

Authors:  Cristina Castro-Alonso; Luis D'Marco; Jaume Pomes; Monserrat Del Amo Conill; Ana Isabel García-Diez; Pablo Molina; María Jesús Puchades; José Manuel Valdivielso; Verónica Escudero; Jordi Bover; Juan Navarro-González; Begoña Ribas; Luis Manuel Pallardo; José Luis Gorriz
Journal:  J Clin Med       Date:  2020-05-25       Impact factor: 4.241

Review 4.  Bone Fragility Fractures in CKD Patients.

Authors:  Ana Pimentel; Pablo Ureña-Torres; Jordi Bover; Jose Luis Fernandez-Martín; Martine Cohen-Solal
Journal:  Calcif Tissue Int       Date:  2020-11-21       Impact factor: 4.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.